• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MEK 抑制剂(PD0325901)的发育剂量挽救了肌肉特异性而非肢体特异性 Nf1 敲除小鼠的肌病特征。

Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse.

机构信息

Orthopaedic Research & Biotechnology, The Children's Hospital at Westmead, Westmead, NSW, Australia; Discipline of Paediatrics & Child Heath, Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia.

Orthopaedic Research & Biotechnology, The Children's Hospital at Westmead, Westmead, NSW, Australia.

出版信息

Mol Genet Metab. 2018 Apr;123(4):518-525. doi: 10.1016/j.ymgme.2018.02.009. Epub 2018 Feb 16.

DOI:10.1016/j.ymgme.2018.02.009
PMID:29477258
Abstract

Neurofibromatosis Type 1 (NF1) is a common autosomal dominant genetic disorder While NF1 is primarily associated with predisposition for tumor formation, muscle weakness has emerged as having a significant impact on quality of life. NF1 inactivation is linked with a canonical upregulation Ras-MEK-ERK signaling. This in this study we tested the capacity of the small molecule MEK inhibitor PD0325901 to influence the intramyocellular lipid accumulation associated with NF1 deficiency. Established murine models of tissue specific Nf1 deletion in skeletal muscle (Nf1) and limb mesenchyme (Nf1) were tested. Developmental PD0325901 dosing of dams pregnant with Nf1 progeny rescued the phenotype of day 3 pups including body weight and lipid accumulation by Oil Red O staining. In contrast, PD0325901 treatment of 4 week old Nf1 mice for 8 weeks had no impact on body weight, muscle wet weight, activity, or intramyocellular lipid. Examination of day 3 Nf1 pups showed differences between the two tissue-specific knockout strains, with lipid staining greatest in Nf1 mice, and fibrosis higher in Nf1 mice. These data show that a MEK/ERK dependent mechanism underlies NF1 muscle metabolism during development. However, crosstalk from Nf1-deficient non-muscle mesenchymal cells may impact upon muscle metabolism and fibrosis in neonatal and mature myofibers.

摘要

神经纤维瘤病 1 型(NF1)是一种常见的常染色体显性遗传疾病。虽然 NF1 主要与肿瘤形成易感性有关,但肌肉无力已成为影响生活质量的重要因素。NF1 的失活与 Ras-MEK-ERK 信号的经典上调有关。在本研究中,我们测试了小分子 MEK 抑制剂 PD0325901 影响与 NF1 缺乏相关的肌内脂质积累的能力。测试了骨骼肌(Nf1)和肢体间充质(Nf1)组织特异性 Nf1 缺失的小鼠模型。对携带 Nf1 后代的孕鼠进行 PD0325901 的发育剂量给药,挽救了第 3 天幼鼠的表型,包括体重和油红 O 染色的脂质积累。相比之下,PD0325901 治疗 4 周龄 Nf1 小鼠 8 周对体重、肌肉湿重、活动或肌内脂质没有影响。对第 3 天 Nf1 幼鼠的检查显示两种组织特异性敲除株之间存在差异,Nf1 小鼠的脂质染色最强,Nf1 小鼠的纤维化程度更高。这些数据表明,MEK/ERK 依赖性机制是 NF1 肌肉代谢在发育过程中的基础。然而,来自 NF1 缺陷的非肌肉间充质细胞的串扰可能会影响新生儿和成熟肌纤维的肌肉代谢和纤维化。

相似文献

1
Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse.MEK 抑制剂(PD0325901)的发育剂量挽救了肌肉特异性而非肢体特异性 Nf1 敲除小鼠的肌病特征。
Mol Genet Metab. 2018 Apr;123(4):518-525. doi: 10.1016/j.ymgme.2018.02.009. Epub 2018 Feb 16.
2
Dietary intervention rescues myopathy associated with neurofibromatosis type 1.饮食干预可挽救神经纤维瘤病 1 型相关的肌病。
Hum Mol Genet. 2018 Feb 15;27(4):577-588. doi: 10.1093/hmg/ddx423.
3
A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis.rhBMP-2(重组人骨形态发生蛋白-2)和 MEK(MAP 激酶/ERK 激酶)抑制剂 PD0325901 联合应用可增加 I 型神经纤维瘤病假关节模型中小鼠的骨形成。
J Bone Joint Surg Am. 2014 Jul 16;96(14):e117. doi: 10.2106/JBJS.M.00862.
4
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.MEK 抑制在人类和小鼠神经纤维瘤肿瘤中显示出疗效。
J Clin Invest. 2013 Jan;123(1):340-7. doi: 10.1172/JCI60578. Epub 2012 Dec 10.
5
Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.Ras-Mek-Erk 信号通路调控 NF1 杂合子血管新生内膜形成。
Am J Pathol. 2014 Jan;184(1):79-85. doi: 10.1016/j.ajpath.2013.09.022. Epub 2013 Nov 7.
6
Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.双重mTORC1/2抑制在与神经纤维瘤病1型相关的丛状神经纤维瘤和恶性外周神经鞘膜瘤细胞中诱导抗增殖作用。
Oncotarget. 2016 Jun 14;7(24):35753-35767. doi: 10.18632/oncotarget.7099.
7
NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.神经纤维瘤病1型(NF1)调节一种依赖Ras的血管平滑肌增殖性损伤反应。
Circulation. 2007 Nov 6;116(19):2148-56. doi: 10.1161/CIRCULATIONAHA.107.707752. Epub 2007 Oct 22.
8
NF1 is a critical regulator of muscle development and metabolism.神经纤维瘤病1型是肌肉发育和代谢的关键调节因子。
Hum Mol Genet. 2014 Mar 1;23(5):1250-9. doi: 10.1093/hmg/ddt515. Epub 2013 Oct 24.
9
Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells.Nf1单倍体不足的间充质干/祖细胞迁移和黏附中的RAS/PI3-K/MAPK信号级联反应亢进
Int J Mol Sci. 2015 Jun 1;16(6):12345-59. doi: 10.3390/ijms160612345.
10
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.持续的 MEK 抑制可消除 NF1 突变小鼠的骨髓增生性疾病。
J Clin Invest. 2013 Jan;123(1):335-9. doi: 10.1172/JCI63193. Epub 2012 Dec 10.

引用本文的文献

1
Unraveling neuronal and metabolic alterations in neurofibromatosis type 1.解析神经纤维瘤病 1 型中的神经元和代谢改变。
J Neurodev Disord. 2024 Aug 31;16(1):49. doi: 10.1186/s11689-024-09565-6.
2
RASopathies - what they reveal about RAS/MAPK signaling in skeletal muscle development.RAS 病——它们揭示了 RAS/MAPK 信号在骨骼肌发育中的作用。
Dis Model Mech. 2024 Jun 1;17(6). doi: 10.1242/dmm.050609. Epub 2024 Jun 7.
3
Long-term retinal protection by MEK inhibition in Pax6 haploinsufficiency mice.MEK 抑制在 Pax6 杂合不足小鼠中的长期视网膜保护作用。
Exp Eye Res. 2022 May;218:109012. doi: 10.1016/j.exer.2022.109012. Epub 2022 Mar 1.
4
MEK-inhibitor-mediated rescue of skeletal myopathy caused by activating Hras mutation in a Costello syndrome mouse model.MEK 抑制剂介导拯救激活 Hras 突变引起的 Costello 综合征小鼠模型中的骨骼肌病。
Dis Model Mech. 2022 Feb 1;15(2). doi: 10.1242/dmm.049166. Epub 2021 Nov 19.
5
MEK inhibitors - novel targeted therapies of neurofibromatosis associated benign and malignant lesions.MEK抑制剂——神经纤维瘤病相关良性和恶性病变的新型靶向治疗方法。
Biomark Res. 2021 Apr 16;9(1):26. doi: 10.1186/s40364-021-00281-0.
6
Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.神经纤维瘤病基因(Nf1)在出生后肌肉肥大生长和代谢稳态中的细胞自主需求。
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1758-1778. doi: 10.1002/jcsm.12632. Epub 2020 Oct 19.